Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry

Table 1

Pretreatment characteristics.

		PORT (𝑛=31)	WPRT (𝑛=57)	P
Age (years)		71.9	73.1	0.57
PSA	Mean	6.9	23.9
	<10 ng/mL	24	20	0.015
	10–20 ng/mL	7	17
	≥20 ng/mL	0	21
Gleason score	Mean	6.42	7.72
	≤6	18	6	<0.01
	=7	13	21
	≥8	0	31
NCCN risk group	Low	15	0
	Intermediate	16	13
	High	0	45
Percent receiving hormonal ablation		39%	88%	<0.01